Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Low levels of zinc and ferritin may worsen alopecia areata.

Tofacitinib effectively treats Alopecia Areata.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Tretinoin alone is more effective than combined with microdermabrasion for long-term alopecia areata treatment.

Systemic minoxidil might help maintain hair regrowth in alopecia areata.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.

Accurate diagnosis is crucial to distinguish alopecia areata incognita from androgenetic alopecia in men for proper treatment.

Oral JAK inhibitors help regrow hair in alopecia patients.

All types of alopecia involve hair follicle damage, especially in alopecia areata.

Hair loss significantly affects quality of life, causing emotional and social challenges.

Alopecia negatively affects quality of life and mental health.

Alopecia significantly harms emotional and social well-being.

Apremilast showed mixed results for treating severe alopecia areata.

Siddha medicine helped a child regrow hair lost from alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Scalp skin barrier affects hair loss; personalized treatments needed.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.